TrialScientific reports2024

Effect of cytokines on advanced hepatocellular carcinoma prognosis receiving radiotherapy and tislelizumab plus anlotinib: a single-center phase II clinical trial.

Yi Dong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.